Ginsenosides protect striatal neurons in a cellular model of Huntington's disease

Journal of Neuroscience Research

Volumn 87, Issue 8, 2009, Pages 1904-1912

  Wu, Jun ^a   Jeong, Hye Kyoung ^b   Bulin, Sarah Elizabeth ^a   Kwon, Sung Won ^b   Park, Jeong Hill ^b   Bezprozvanny, Ilya ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Seoul National University   (South Korea)

Author keywords

Apoptosis; Excitotoxicity; Ginseng; Ginsenosides; Huntington's disease; Transgenic mouse

Indexed keywords

CALCIUM; GINSENG EXTRACT; GINSENOSIDE; GINSENOSIDE RB 1; GINSENOSIDE RC; GINSENOSIDE RG5; GLUTAMIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG POTENCY; FEMALE; HUNTINGTON CHOREA; MOUSE; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; STRIATE CORTEX; WILD TYPE;

ANIMALS; CALCIUM SIGNALING; CELLS, CULTURED; CORPUS STRIATUM; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; FEMALE; GINSENOSIDES; GLUTAMIC ACID; HUNTINGTON DISEASE; MALE; MICE; MICE, NEUROLOGIC MUTANTS; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; TREATMENT OUTCOME;

EID: 66049095622     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22017     Document Type: Article

References (38)

1. Bezprozvanny I, Hayden MR. 2004. Deranged neuronal calcium signaling and Huntington disease. Biochem Biophys Res Commun 322: 1310-1317.
2. Cepeda C, Wu N, Andre VM, Cummings DM, Levine MS. 2007. The corticostriatal pathway in Huntington's disease. Prog Neurobiol 81: 253-271.
3. Chen N, Luo T, Wellington C, Metzler M, McCutcheon K, Hayden MR, Raymond LA. 1999. Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin. J Neurochem 72:1890-1898.
4. Choo YS, Johnson GV, MacDonald M, Detloff PJ, Lesort M. 2004. Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum Mol Genet 13:1407-1420.
5. Greenblatt DJ, von Moltke LL. 2005. Interaction of warfarin with drugs, natural substances, and foods. J Clin Pharmacol 45:127-132.
6. Gu X, Li C, Wei W, Lo V, Gong S, Li SH, Iwasato T, Itohara S, Li XJ, Mody I, Heintz N, Yang XW. 2005. Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice. Neuron 46:433-444.
7. Gu X, Andre VM, Cepeda C, Li SH, Li XJ, Levine MS, Yang XW. 2007. Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease. Mol Neurodegen 2:8.
8. Gyllenhaal C, Merritt SL, Peterson SD, Block KI, Gochenour T. 2000. Efficacy and safety of herbal stimulants and sedatives in sleep disorders. Sleep Med Rev 4:229-251.
9. Jeong SM, Lee JH, Kim JH, Lee BH, Yoon IS, Kim DH, Rhim H, Kim Y, Nah SY. 2004. Stereospecificity of ginsenoside Rg3 action on ion channels. Mol Cells 18:383-389.
10. Kim JH, Kim S, Yoon IS, Lee JH, Jang BJ, Jeong SM, Lee BH, Han JS, Oh S, Kim HC, Park TK, Rhim H, Nah SY. 2005. Protective effects of ginseng saponins on 3-nitropropionic acid-induced striatal degeneration in rats. Neuropharmacology 48:743-756.
11. Kim S, Ahn K, Oh TH, Nah SY, Rhim H. 2002. Inhibitory effect of ginsenosides on NMDA receptor-mediated signals in rat hippocampal neurons. Biochem Biophys Res Commun 296:247-254.
12. Kim S, Kim T, Ahn K, Park WK, Nah SY, Rhim H. 2004. Ginsenoside Rg3 antagonizes NMDA receptors through a glycine modulatory site in rat cultured hippocampal neurons. Biochem Biophys Res Commun 323:416-424.
13. Kim YC, Kim SR, Markelonis GJ, Oh TH. 1998. Ginsenosides Rb1 and Rg3 protect cultured rat cortical cells from glutamate-induced neurodegeneration. J Neurosci Res 53:426-432.
14. Kwon SW, Han SB, Park IH, Kim JM, Park MK, Park JH. 2001. Liquid chromatographic determination of less polar ginsenosides in processed ginseng. J Chromatogr A921:335-339.
15. Lee E, Kim S, Chung KC, Choo MK, Kim DH, Nam G, Rhim H. 2006. 20(S)-ginsenoside Rh2, a newly identified active ingredient of ginseng, inhibits NMDA receptors in cultured rat hippocampal neurons. Eur J Pharmacol 536:69-77.
16. v1.4 channel currents by interacting with the Lys531 residue. Mol Pharmacol 73:619-626.
17. Lian XY, Zhang Z, Stringer JL. 2005. Protective effects of ginseng components in a rodent model of neurodegeneration. Ann Neurol 57:642-648.
18. Macdonald V, Halliday GM, Trent RJ, McCusker EA. 1997. Significant loss of pyramidal neurons in the angular gyrus of patients with Huntington's disease. Neuropathol Appl Neurobiol 23:492-495.
19. Mao L, Wang JQ. 2001. Upregulation of preprodynorphin and preproenkephalin mRNA expression by selective activation of group I metabotropic glutamate receptors in characterized primary cultures of rat striatal neurons. Brain Res Mol Brain Res 86:125-137.
20. Nah SY, Kim DH, Rhim H. 2007. Ginsenosides: are any of them candidates for drugs acting on the central nervous system? CNS Drug Rev 13:381-404.
21. Panov AV, Gutekunst CA, Leavitt BR, Hayden MR, Burke JR, Strittmatter WJ, Greenamyre JT. 2002. Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat Neurosci 5:731-736.
22. Park IH, Kim NY, Han SB, Kim JM, Kwon SW, Kim HJ, Park MK, Park JH. 2002. Three new dammarane glycosides from heat processed ginseng. Arch Pharm Res 25:428-432.
23. 2+ channel currents in rat sensory neurons. Eur J Pharmacol 436:151-158.
24. Shehadeh J, Fernandes HB, Zeron Mullins MM, Graham RK, Leavitt BR, Hayden MR, Raymond LA. 2006. Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease. Neurobiol Dis 21:392-403.
25. Slow EJ, van Raamsdonk J, Rogers D, Coleman SH, Graham RK, Deng Y, Oh R, Bissada N, Hossain SM, Yang YZ, Li XJ, Simpson EM, Gutekunst CA, Leavitt BR, Hayden MR. 2003. Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet 12:1555-1567.
26. Sotrel A, Paskevich PA, Kiely DK, Bird ED, Williams RS, Myers RH. 1991. Morphometric analysis of the prefrontal cortex in Huntington's disease. Neurology 41:1117-1123.
27. Sun Y, Savanenin A, Reddy PH, Liu YF. 2001. Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via postsynaptic density 95. J Biol Chem 276:24713-24718.
28. Tang T-S, Tu H, Chan EY, Maximov A, Wang Z, Wellington CL, Hayden MR, Bezprozvanny I. 2003. Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1. Neuron 39:227-239.
29. 2+ signaling and apoptosis of medium spiny neurons in Huntington's disease. Proc Natl Acad Sci U S A 102:2602-2607.
30. The Huntington's Disease Collaborative Research Group 1993. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971-983.
31. Vazquez I, Aguera-Ortiz LF. 2002. Herbal products and serious side effects: a case of ginseng-induced manic episode. Acta Psychiatr Scand 105:76-77; discussion 77-78.
32. Vonsattel JP, DiFiglia M. 1998. Huntington disease. J Neuropathol Exp Neurol 57:369-384.
33. Wen TC, Yoshimura H, Matsuda S, Lim JH, Sakanaka M. 1996. Ginseng root prevents learning disability and neuronal loss in gerbils with 5-minute forebrain ischemia. Acta Neuropathol 91:15-22.
34. Wu J, Tang T-S, Bezprozvanny I. 2006. Evaluation of clinically relevant glutamate pathway inhibitors in in vitro model of Huntington's disease. Neurosci Lett 407:219-223.
35. Xie JT, McHendale S, Yuan CS. 2005. Ginseng and diabetes. Am J Chin Med 33:397-404.
36. Zeron MM, Hansson O, Chen N, Wellington CL, Leavitt BR, Brundin P, Hayden MR, Raymond LA. 2002. Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron 33:849-860.
37. Zhang B, Hata R, Zhu P, Sato K, Wen TC, Yang L, Fujita H, Mitsuda N, Tanaka J, Samukawa K, Maeda N, Sakanaka M. 2006. Prevention of ischemic neuronal death by intravenous infusion of a ginseng saponin, ginsenoside Rb(1), that upregulates Bcl-x(L) expression. J Cereb Blood Flow Metab 26:708-721.
38. 2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease. Neurobiol Dis 31:80-88.